The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.a

Pneumonitis (interstitial lung disease/ILD)

Publications

Abelleira R, Elena Toubes M, Suárez-Antelo J, Valdés L

Reversible diffuse lung disease after mycophenolate mofetil withdrawal.

Pulmonology 2018 Nov - Dec;24;361-362 — 2018 Nov - Dec — 361-362

Anandh U, Marda S

Unusual Case of Acute Lung Injury in a Renal Allograft Recipient.

Indian journal of nephrology 2017 May-Jun;27;215-217 — 2017 May-Jun — 215-217

Tull TJ, Toma T, Menagé HP

Reversible interstitial lung disease following treatment of atopic dermatitis with mycophenolate mofetil.

Clinical and experimental dermatology 2016 Aug;41;702-3 — 2016 Aug — 702-3

Wan QJ, Hu HF, He YC, Luan SD, Chen HT, Liu HP, Li T, Xu Y, Xu HL, Liao Y

Severe pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy.

The Kaohsiung journal of medical sciences 2015 Jan;31;42-6 — 2015 Jan — 42-6

Shrestha NK, Mossad SB, Braun W

Pneumonitis associated with the use of mycophenolate mofetil.

Transplantation 2003 May 27;75;1762 — 2003 May 27 — 1762